BN52021 protects rat cardiomyocyte from doxorubicin induced cardiotoxicity

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 2, 2015, Pages 1719-1724

  Yan, Wen ^a   Xuan, Chengluan ^a,b   Xuan, Lei ^c   Xu, Rihao ^a   Wang, Junnan ^a  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

BN52021; Calcium signaling; Cardiotoxicity; Doxorubicin; MAPK signaling

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; GINKGOLIDE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CARDIAC MUSCLE CELL; CARDIOMYOPATHY; CARDIOTOXICITY; CELL LINE; CELL SURVIVAL; CHEMICALLY INDUCED; DRUG EFFECTS; RAT; TUNEL ASSAY; WESTERN BLOTTING;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; CARDIOMYOPATHIES; CARDIOTOXICITY; CELL LINE; CELL SURVIVAL; DOXORUBICIN; GINKGOLIDES; IN SITU NICK-END LABELING; MYOCYTES, CARDIAC; PLATELET ACTIVATING FACTOR; RATS;

EID: 84928158919     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ and Moens AL. Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 2012; 52: 1213-1225.
2. Jain D. Cardiotoxicity of doxorubicin and other anthracycline derivatives. J Nucl Cardiol 2000; 7: 53-62.
3. Ludke AR, Al-Shudiefat AA, Dhingra S, Jassal DS and Singal PK. A concise description of cardioprotective strategies in doxorubicin-induced cardiotoxicity. Can J Physiol Pharmacol 2009; 87: 756-763.
4. Yang Y, Nemoto EM, Harvey SA, Subbotin VM and Gandhi CR. Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis. Gut 2004; 53: 877-883.
5. Xia SH, Hu CX, Fang JM, Di Y, Zhao ZL and Liu LR. G[alpha]i2 and G[alpha]q expression change in pancreatic tissues and BN52021 effects in rats with severe acute pancreatitis. Pancreas 2008; 37: 170-175.
6. Mahmoud F, Abul H, Onadeko B, Khadadah M, Haines D and Morgan G. In vitro effects of Ginkgolide B on lymphocyte activation in atopic asthma: Comparison with cyclosporin a. Jpn J Pharmacol 2000; 83: 241-245.
7. Spallarossa P, Altieri P, Garibaldi S, Ghigliotti G, Barisione C, Manca V, Fabbi P, Ballestrero A, Brunelli C and Barsotti A. Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase. Cardiovasc Res 2006; 69: 736-745.
8. Minotti G, Menna P, Salvatorelli E, Cairo G and Gianni L. Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004; 56: 185-229.
9. 2+: A control point for apoptosis. Science 2003; 300: 135-139.
10. Spallarossa P, Altieri P, Barisione C, Passalacqua M, Aloi C, Fugazza G, Frassoni F, Podesta M, Canepa M, Ghigliotti G and Brunelli C. P38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells. PLoS One 2010; 5: e15583.
11. Venkatesan B, Prabhu SD, Venkatachalam K, Mummidi S, Valente AJ, Clark RA, Delafontaine P and Chandrasekar B. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death. Cell Signal 2010; 22: 809-820.
12. Liu WC, Ding WL, Gu HY, Chen MF and Hu JJ. Lipopolysaccharide-induced cerebral inflammatory damage and the therapeutic effect of platelet activating factor receptor antagonist. Neurosci Bull 2007; 23: 271-276.
13. 2+-dependent manner. Int J Cardiol 2010; 143: 86-93.
14. 2+ increase are reciprocally modulated in rat cardiomyocytes. Exp Mol Med 2006; 38: 535-545.
15. Spallarossa P, Altieri P, Aloi C, Garibaldi S, Barisione C, Ghigliotti G, Fugazza G, Barsotti A and Brunelli C. Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2. Am J Physiol Heart Circ Physiol 2009; 297: H2169-H2181.
16. Nelyudova A, Aksenov N, Pospelov V and Pospelova T. By blocking apoptosis, Bcl-2 in p38-dependent manner promotes cell cycle arrest and accelerated senescence after DNA damage and serum withdrawal. Cell Cycle 2007; 6: 2171-2177.
17. Thandavarayan RA, Watanabe K, Sari FR, Ma M, Lakshmanan AP, Giridharan VV, Gurusamy N, Nishida H, Konishi T, Zhang S, Muslin AJ, Kodama M and Aizawa Y. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38alpha mitogen-activated protein kinase mice. Free Radic Biol Med 2010; 49: 1422-1431.
18. Wold LE, Aberle NN and Ren J. Doxorubicin induces cardiomyocyte dysfunction via a p38 MAP kinase-dependent oxidative stress mechanism. Cancer Detect Prev 2005; 29: 294-299.